Clinical trials
Phase 3 Coronary Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
144 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 10 |
| 2004 | 6 |
| 2005 | 6 |
| 2006 | 10 |
| 2007 | 7 |
| 2008 | 10 |
| 2009 | 7 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2019 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 125 |
| Unknown status | 10 |
| Terminated | 4 |
| Withdrawn | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 37 |
| Organon and Co | 7 |
| AstraZeneca | 6 |
| Abbott | 5 |
| University of Washington | 5 |
| Abbott Medical Devices | 3 |
| Brigham and Women's Hospital | 3 |
| Hoffmann-La Roche | 3 |
| Amgen | 2 |
| Carelon Research | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Disease | 144 |
| Cardiovascular Diseases | 70 |
| Heart Diseases | 65 |
| Myocardial Ischemia | 56 |
| Myocardial Infarction | 28 |
| Hypercholesterolemia | 20 |
| Coronary Artery Disease | 19 |
| Atherosclerosis | 12 |
| Dyslipidemias | 11 |
| Diabetes Mellitus | 10 |
Trials
Showing 1 to 25 of 144. Each trial links to its page on Pharma Observatory.
44 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.